Crosstalk between dopamine and glucocorticoids in high levels of nicotine intake and anhedonia in rats

NIH Pandemic-Era Grants

Pandemic Era Grants

2024

Document text

Principal Investigator: Adriaan Willem Bruijnzeel
Organization: UNIVERSITY OF FLORIDA
Fiscal Year: 2024
Award: $343,125
Funding agency: National Institute on Drug Abuse

SUMMARY
Smoking is addictive and most smokers would like to quit. However, even with treatment, only a small
percentage of smokers quits successfully. Clinical studies indicate that smoking cessation leads to anhedonia,
which increases the risk for relapse. Nicotine induces the release of dopamine (DA), which plays a role in
establishing habitual smoking, while the activation of stress systems has been suggested to mediate
withdrawal and anhedonia. Virtually all animal studies have been conducted with nondependent rodents that
had limited or short access to nicotine. Therefore, very little is known about the mechanisms that mediate
withdrawal and self-administration in dependent animals with high levels of nicotine intake. To develop new
smoking cessation treatments, more insight is needed into the neurobiological mechanisms that mediate
withdrawal and nicotine intake in animals that have become dependent by self-administering nicotine. The
long-term goal of this research program is to determine the adaptations in the reward system that cause high
levels of nicotine intake and anhedonia in dependent animals. The objective of our studies is to determine the
role of DA and the stress hormone corticosterone (CORT) in nicotine self-administration in dependent animals
and withdrawal-induced anhedonia. It is proposed to use an intermittent long access model to obtain high
levels of nicotine intake and induce dependence. Our preliminary studies point to a role for DA in high levels of
nicotine intake in dependent animals, and brain stress systems in the anhedonia associated with withdrawal.
Based on our studies, it is hypothesized that DA transmission and glucocorticoid receptor (GR) signaling in the
nucleus accumbens (Nacc) are pivotal for high levels of nicotine intake and anhedonia associated with nicotine
withdrawal. Three aims are proposed to test this hypothesis. 1) Determine the relationship between nicotine
intake and reward function in dependent (long access) and nondependent (short access) animals. 2)
Determine the role of DA signaling in nicotine intake in dependent and nondependent animals. 3) Determine
the role of DA-CORT interactions in the Nacc in nicotine intake and anhedonia in dependent and
nondependent animals. To investigate the relationship between nicotine intake and reward function, male and
female rats will be prepared with intravenous catheters and intracranial self-stimulation (ICSS) electrodes. The
ICSS method provides an objective measure of reward function. Dopamine antagonists and transgenic D1-Cre
and D2-Cre rats will be used to determine the role of D1 and D2 neurons in the Nacc in high levels of nicotine
intake and withdrawal. It is predicted that D1 receptors play a critical role in nicotine intake in dependent and
nondependent animals. It is also expected that blockade of GR will decrease nicotine intake in dependent
animals, prevents the decrease in DA levels in the Nacc during withdrawal, and diminishes anhedonia
associated with nicotine withdrawal. The studies will provide insight into the role of DA and CORT in the Nacc
in high levels of nicotine self-administration in dependent animals and withdrawal-induced anhedonia.

Terms: <Acute><Affect><Anhedonia><Animal Model><Animal Models and Related Studies><Animals><Autoregulation><Behavior><Brain><Brain Nervous System><CRE Recombinase><Catheters><Cell Communication and Signaling><Cell Signaling><Clinical Research><Clinical Study><Common Rat Strains><Corticosterone><D1 receptor><D2 receptor><DRD2 Receptor><DREADDs><Dependence><Development><Dialysis><Dialysis procedure><Dopamine><Dopamine Antagonists><Dopamine D1 Receptor><Dopamine D2 Receptor><Dopamine Receptor Antagonists><Dopaminergic Antagonists><Electrodes><Emotional Depression><Encephalon><Endocrine Gland Secretion><Enterobacteria phage P1 Cre recombinase><Evaluation><Female><Glucocorticoid Receptor><Glucocorticoids><Goals><Homeostasis><Hormones><Hydroxytyramine><Injections><Intake><Intracellular Communication and Signaling><Intravenous><Knowledge><Measures><Medial Forebrain Bundle><Mediating><Methods><Microdialysis><Modeling><Nerve Cells><Nerve Unit><Neural Cell><Neurocyte><Neurons><Neuropeptides><Nicotine><Nicotine Dependence><Nicotine Withdrawal><Nicotinic Acetylcholine Receptors><Nicotinic Receptors><Nucleus Accumbens><Persons><Physiological Homeostasis><Play><Property><Pump><Rat><Rat Transgene><Rats Mammals><Rattus><Receptor Activation><Receptor Signaling><Relapse><Research><Rewards><Rodent><Rodentia><Rodents Mammals><Role><Self Administered><Self Administration><Self Stimulation><Signal Transduction><Signal Transduction Systems><Signaling><Smoke><Smoker><Smoking><Smoking Cessation Intervention><Stress><System><Testing><Therapeutic Hormone><Time><Tobacco><Transgenic Organisms><Transmission><Withdrawal><Work><antagonism><antagonist><bacteriophage P1 recombinase Cre><biological signal transduction><cease smoking><depression symptom><depressive><depressive symptoms><designer receptors exclusively activated by designer drugs><developmental><dialysis therapy><drug relapse><experiment><experimental research><experimental study><experiments><insight><male><median forebrain bundle><model of animal><neurobiological mechanism><neuronal><nicotine addiction><nicotine cessation><nicotine dependent><nicotine self-administration><prevent><preventing><programs><quit smoking><relapse risk><smoke addiction><smoking addiction><smoking and dependence><smoking cessation><smoking cessation treatment><smoking dependence><smoking dependent><social role><stop smoking><transgenic><transmission process><virtual>